A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics with AZD0780 following repeated dose administration in healthy adults with elevated LDL-C levels

Trial Identifier:	D7960C00021
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	February 2026
Primary Completion Date:	June 2026
Study Completion Date:	June 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.